Catalyst Pharmaceuticals
CPRX
#3987
Rank
$2.89 B
Marketcap
$23.53
Share price
1.95%
Change (1 day)
6.86%
Change (1 year)

Market capitalization of Catalyst Pharmaceuticals (CPRX)

Market cap: $2.89 Billion USD

As of December 2025 Catalyst Pharmaceuticals has a market cap of $2.89 Billion USD. This makes Catalyst Pharmaceuticals the world's 3987th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalyst Pharmaceuticals from 2006 to 2025

End of year Market Cap

Year Marketcap Change
2025$2.89 B12.94%
2024$2.56 B42.89%
2023$1.79 B-7.42%
2022$1.93 B177.62%
2021$0.69 B101.15%
2020$0.34 B-10.6%
2019$0.38 B96.56%
2018$0.19 B-50.77%
2017$0.40 B360.32%
2016$87.04 M-57.12%
2015$0.20 B-1.12%
2014$0.20 B94.47%
2013$0.10 B485.85%
2012$18.01 M-43.45%
2011$31.86 M65.96%
2010$19.2 M68.96%
2009$11.36 M-55.1%
2008$25.3 M-41.44%
2007$43.22 M-28.51%
2006$60.45 M

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Catalyst Pharmaceuticals was reported to be:

$2.89 Billion USD
by Nasdaq info icon info icon
$2.89 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioMarin Pharmaceutical
BMRN
$10.25 B 254.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
$2.33 B-19.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$486.50 B 16,721.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
$0.82 M-99.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$147.99 B 5,017.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$217.69 B 7,427.21%๐Ÿ‡บ๐Ÿ‡ธ USA